COMMITTEES
Home /
Committees

The PHRMAG Executive Committee (EC) comprises of experienced industry leaders that are committed to
providing strategic counsel, and serve as mentors for PHMRAG working groups. The PHRMAG EC plays a crucial
role in fostering collaboration, and driving our mission forward in the Gulf region.

Sameh El Fangary
Chairman
Cluster President, AstraZeneca
GCC & Pakistan


Ashraf Mallak
Vice Chairman
Managing Director GCC, MSD


Diederik Kok
EC Member & Treasurer
Head of GCC, Biogen


Ahmed Aboelfadl
EC Member
General Manager Gulf, Merck Serono


Shahad Mahdi
Secretary General
PHRMAG


Elhussein Abdellatif
EC Member
General Manager Gulf & Levant, AbbVie Biopharmaceuticals
GmbH


Roberta Marinelli
EC Member
President and General Manager, Meta Hub, Eli Lilly


Pedro Matos Rosa
EC Member
General Manager, Johnson & Johnson Innovative Medicines Gulf

Working Groups
The Working Groups at PHRMAG are dedicated to driving progress and excellence across geographies and in various key functional areas, These committees are strategically aligned with our mission and the needs of the healthcare ecosystems to help address important industry challenges, shape policies, and ensure compliance with ethical standards.

Compliance and Legal
Lead: Youssef Mourad (Roche)
Mentor: Sameh El Fangary (AstraZeneca)


Value and Access
Lead: Yomna Nowier (Novartis)
Mentor: Pedro Matos Rosa (Johnson & Johnson)


Qatar, Oman & Bahrain
Lead: Sally Berri
Mentor: Roberta Marinelli (Eli Lilly)


Regulation EDE
Lead: Ibrahim Aqel
Mentor: Diedrick Kok (Biogen)


Regulation DOH, DHA, MOHAP
Lead: Ghaleb Al Ahdab (Boehringer Ingelheim)
Mentor: Ashraf Mallak (MSD)


IP and Policy Working
Lead: Samia Kanawati
Mentor: Ahmed Abou Fadl (Merck)


Kuwait
Lead: Abdelrahman Elkhouly
Mentor: Elhussein Abdellatif


Communications
Lead: Joy Khoury (Novartis)
